These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26090373)

  • 1. Advanced Anderson-Fabry disease presenting with left ventricular apical aneurysm and ventricular tachycardia.
    Poulin MF; Shah A; Trohman RG; Madias C
    World J Clin Cases; 2015 Jun; 3(6):519-24. PubMed ID: 26090373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification.
    Chang HC; Kuo L; Sung SH; Weng CY; Chen CK; Niu DM; Chen SA; Yu WC
    J Am Heart Assoc; 2023 Jan; 12(1):e027041. PubMed ID: 36583432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.
    Gruner C; Verocai F; Carasso S; Vannan MA; Jamorski M; Clarke JT; Care M; Iwanochko RM; Rakowski H
    Echocardiography; 2012 Aug; 29(7):810-7. PubMed ID: 22497597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.
    Deva DP; Hanneman K; Li Q; Ng MY; Wasim S; Morel C; Iwanochko RM; Thavendiranathan P; Crean AM
    J Cardiovasc Magn Reson; 2016 Mar; 18():14. PubMed ID: 27036375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Phenotypes of Anderson-Fabry Disease Identified with Cardiac Magnetic Resonance Imaging in a Family with the Same Late-Onset Mutation.
    Ávila-Sánchez DA; Cambronero-Cortinas E; Barreiro-Pérez M; Rodríguez-Hernández JL; Díaz-Fernández B; Sánchez PL
    Am J Case Rep; 2020 Oct; 21():e925631. PubMed ID: 33119553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: prevalence, cardiac magnetic resonance characteristics, and prognosis.
    Yang K; Song YY; Chen XY; Wang JX; Li L; Yin G; Zheng YC; Wei MD; Lu MJ; Zhao SH
    Eur Heart J Cardiovasc Imaging; 2020 Dec; 21(12):1341-1350. PubMed ID: 32888301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison on CMR characteristics and clinical prognosis between hypertrophic cardiomyopathy patients with and without left ventricular apical aneurysms].
    Song YY; Lu MJ; Li L; Cui C; Cheng HB; Chen XY; Yin G; Zhao SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Mar; 47(3):204-208. PubMed ID: 30897879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of conventional echocardiographic features in apical hypertrophic cardiomyopathy patients complicated with left ventricular apical aneurysm].
    Zhao Y; Wang H; Yang K; Lin JR; Quan X; Qu R; Zhao SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Oct; 51(10):1075-1079. PubMed ID: 37859360
    [No Abstract]   [Full Text] [Related]  

  • 10. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.
    Putko BN; Wen K; Thompson RB; Mullen J; Shanks M; Yogasundaram H; Sergi C; Oudit GY
    Heart Fail Rev; 2015 Mar; 20(2):179-91. PubMed ID: 25030479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey.
    Elliott P; Baker R; Pasquale F; Quarta G; Ebrahim H; Mehta AB; Hughes DA;
    Heart; 2011 Dec; 97(23):1957-60. PubMed ID: 21890869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and cardiac magnetic resonance features of apical hypertrophic cardiomyopathy patients complicating with left ventricular apical aneurysm].
    Yang K; Zhao SH; Lu MJ; Song YY; Li L; Chen XY; Yin G; Wei MD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jul; 47(7):534-538. PubMed ID: 31365993
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical Distribution of Late Gadolinium Enhancement of the Left Ventricle on Cardiac Magnetic Resonance in Classical Anderson-Fabry Disease.
    Kasuya S; Suzuki M; Inaoka T; Odashima M; Nakatsuka T; Ishikawa R; Tokuyama W; Terada H
    J Belg Soc Radiol; 2016 Jan; 100(1):6. PubMed ID: 30151436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cardiac imaging in Anderson-Fabry cardiomyopathy.
    Serra W; Marziliano N
    Cardiovasc Ultrasound; 2019 Jan; 17(1):1. PubMed ID: 30674321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse phenotypic expression associated with the same genetic variant in female heterozygote patients of Anderson-Fabry disease: a case series.
    Tomioka D; Kato K; Ozawa T; Kodama K; Takahashi H; Dochi K; Ueno Y; Nakagawa Y
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa538. PubMed ID: 33598617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women.
    Faro DC; Losi V; Rodolico MS; Torrisi EM; Colomba P; Duro G; Monte IP
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Asian Fabry Cardiomyopathy High-Risk Screening Study 2 (ASIAN-FAME-2): Prevalence of Fabry Disease in Patients with Left Ventricular Hypertrophy.
    Leung SP; Dougherty S; Zhang XY; Kam KKH; Chi WK; Chan JYS; Fung E; Wong JKT; Choi PCL; Chan DKH; Sheng B; Lee AP
    J Clin Med; 2024 Jul; 13(13):. PubMed ID: 38999464
    [No Abstract]   [Full Text] [Related]  

  • 18. Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping.
    Walter TC; Knobloch G; Canaan-Kuehl S; Greiser A; Sandek A; Blaschke D; Denecke T; Hamm B; Makowski MR
    Acta Radiol; 2017 Aug; 58(8):914-921. PubMed ID: 27799574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic Consequences of Hypertrophic Cardiomyopathy with Midventricular Obstruction: Apical Aneurysm and Thrombus Formation.
    Saba SG; Ertel AW; Siegenthaler M; Bodurian E; Kellman P; Chen MY; Arai AE; Bandettini WP
    J Gen Pract (Los Angel); 2014 Jul; 2(4):. PubMed ID: 27019860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of apical hypertrophic cardiomyopathy: Development of mid-ventricular obstruction and apical aneurysm 11 years after initial diagnosis.
    Singam NSV; Stoddard MF
    Echocardiography; 2019 May; 36(5):987-991. PubMed ID: 30868653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.